Neoadjuvant chemotherapy with biweekly pegilated liposomal doxorubicin (CAELYX) and weekly paclitaxel in locally-advanced breast cancer. Preliminary results

被引:0
|
作者
Baldelli, A. M. [1 ]
Rossi, D. [1 ]
Alessandroni, P. [1 ]
Fedeli, S. Luzi [1 ]
Fedeli, A. [1 ]
Giordani, P. [1 ]
Catalano, V. [1 ]
Casadei, V. [1 ]
Catalano, G. [1 ]
机构
[1] S Salvatore Hosp, Oncol Unit, Pesaro, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:13 / 13
页数:1
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer
    Rossi, David
    Baldelli, Anna Maria
    Casadei, Virginia
    Fedeli, Stefano Luzi
    Alessandroni, Paolo
    Catalano, Vincenzo
    Giordani, Paolo
    Ceccolini, Monica
    Graziano, Francesco
    Catalano, Giuseppina
    [J]. ANTI-CANCER DRUGS, 2008, 19 (07) : 733 - 737
  • [2] Neoadjuvant chemotherapy in locally-advanced breast cancer:: A preliminary report
    Baltali, E
    Firat, D
    Öncel, N
    Onat, DA
    Atahan, IL
    Büyükünal, E
    Çelik, I
    Aktan, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S35 - S35
  • [3] Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx®) and paclitaxel in locally advanced breast cancer:: a phase II study by the Hellenic Cooperative Oncology Group
    Gogas, H
    Papadimitriou, C
    Kalofonos, HP
    Bafaloukos, D
    Fountzilas, G
    Tsavdaridis, D
    Anagnostopoulos, A
    Onyenadum, A
    Papakostas, P
    Economopoulos, T
    Christodoulou, C
    Kosmidis, P
    Markopoulos, C
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (11) : 1737 - 1742
  • [4] Biweekly pegylated liposomal doxorubicin (Caelyx/Doxil) in heavily pretreated patients with metastatic breast cancer.
    Schmid, P
    Schulz, CO
    Dieing, A
    Lehenbauer-Dehm, S
    Flath, RA
    Sezer, O
    Possinger, K
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S204 - S204
  • [5] Liposome-encapsulated doxorubicin plus paclitaxel and trastuzumab as neoadjuvant chemotherapy for operable and locally advanced breast cancer.
    Rossi, D.
    Pistilli, B.
    Morale, D.
    Baldelli, A.
    Casadei, V.
    Benedetti, G.
    Fedeli, S. Luzi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Neoadjuvant chemotherapy in locally advanced breast cancer.
    Soraya, Sami Sahnoun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer
    Vujaskovic, Zeljko
    Kim, Dong W.
    Jones, Ellen
    Lan, Lan
    Mccall, Linda
    Dewhirst, Mark W.
    Craciunescu, Oana
    Stauffer, Paul
    Liotcheva, Vlayka
    Betof, Allison
    Blackwell, Kimberly
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2010, 26 (05) : 514 - 521
  • [8] Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a Phase II study
    Rigatos, SK
    Tsavdaridis, D
    Athanasiadis, A
    Stathopoulos, JG
    Stathopoulos, GP
    [J]. ONCOLOGY REPORTS, 2003, 10 (06) : 1817 - 1819
  • [9] Single Agent Weekly Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Feasibility Study
    Gupta, S.
    Bharath, R.
    Shet, T.
    Desai, S. B.
    Patil, V. M.
    Bakshi, A.
    Parmar, V.
    Badwe, R. A.
    [J]. CLINICAL ONCOLOGY, 2012, 24 (09) : 604 - 609
  • [10] A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel and hyperthermia in locally advanced breast cancer
    Kim, D. W.
    Blackwell, K.
    Vujaskovic, Z.
    Craciunescu, O.
    Stauffer, P.
    Liotcheva, V.
    Jones, E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S183 - S184